CARsgen® U.S. Clinical Holds Lifted by FDA

SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,

Home Previous 202 203 204 205 206 207 208 Next Tail

10 Items Per Page (Page 205 / 563) Total 5622 Items

©copyright2009-2020 British Weekly      Contact Us   SiteMap